Michal Vráblík
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 38
- Surgery top 5%
- Lipoproteins and Cardiovascular Health 90
- Cancer Research top 10%
- Cancer, Lipids, and Metabolism 38
-
- Lipid metabolism and disorders 15
- Blood Pressure and Hypertension Studies 7
- Pharmacology top 5%
-
- Health Systems, Economic Evaluations, Quality of Life 12
- Pharmaceutical Economics and Policy 11
-
- Nutritional Studies and Diet 7
- Co-authors
- R ČeškaJaroslav A. HubáčekMaciej BanachLukáš ZlatohlávekVěra AdámkováAleš HořínekTomáš ŠtulcTomáš Freiberger
- Journals
- SHILAP Revista de lepidopterología (1 paper)PLoS ONE (2 papers)International Journal of Molecular Sciences (1 paper)
- Partner nations
- CzechiaUnited StatesItaly
In The Last Decade
Michal Vráblík
147 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 118
- Endocrinology, Diabetes and Metabolism 501
- Surgery 946
- Cancer Research 257
- Cardiology and Cardiovascular Medicine 387
- Pharmacology 109
Countries citing papers authored by Michal Vráblík
This map shows the geographic impact of Michal Vráblík's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michal Vráblík with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michal Vráblík more than expected).
Fields of papers citing papers by Michal Vráblík
This network shows the impact of papers produced by Michal Vráblík. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michal Vráblík. The network helps show where Michal Vráblík may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Michal Vráblík, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2026 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2023 | 35 | |
| 4 | 2023 | 9 | |
| 5 | 2021 | 19 | |
| 6 | 2021 | 42 | |
| 7 | 2019 | 4 | |
| 8 | 2019 | 2 | |
| 9 | 2019 | 2 | |
| 10 | Společné stanovisko odborných společností k předepisování inhibitorů PCSK9 | 2018 | 0 |
| 11 | 2018 | 1 | |
| 12 | [Familial hypercholesterolemia in the Czech Republic in 2016]. | 2017 | 1 |
| 13 | [PCSK9 inhibitors - new possibilities in the treatment of hypercholesterolemia: For which patients will be indicated?Czech atherosclerosis society statement]. | 2016 | 1 |
| 14 | [Dietary changes in relationship to risk factors and coronary heart disease mortality]. | 2015 | 1 |
| 15 | [Early diagnosis of familial hypercholesterolemia in Czech Republic in pursuance of MedPed Project]. | 2015 | 2 |
| 16 | Stanovisko výboru ČSAT k doporučením ESC/EAS pro diagnostiku a léčbu dyslipidemií z roku 2011 | 2013 | 0 |
| 17 | Komentář k Evropským doporučeným postupům prevence kardiovaskulárních onemocnění v klinické praxi, verze 2012 | 2013 | 1 |
| 18 | Adherence v léčbě hypertenze: pomohou nové lékové formy? | 2012 | 1 |
| 19 | [Effect of early onset of transdermal and oral estrogen therapy on the lipid profile: a prospective study with cross-over design]. | 2006 | 1 |
| 20 | 2001 | 21 |
About Michal Vráblík
Michal Vráblík is a scholar working on Endocrinology, Diabetes and Metabolism, Cancer Research and Surgery, having authored 167 papers that have together received 2.0k indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (90 papers), Cancer, Lipids, and Metabolism (38 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (38 papers), Lipid metabolism and disorders (15 papers), Health Systems, Economic Evaluations, Quality of Life (12 papers), Pharmaceutical Economics and Policy (11 papers), Nutritional Studies and Diet (7 papers) and Blood Pressure and Hypertension Studies (7 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (501 citations), Surgery (946 citations) and Cancer Research (257 citations). Michal Vráblík has collaborated with scholars based in Czechia, United States and Italy. Frequent co-authors include R Češka, Jaroslav A. Hubáček, Maciej Banach, Lukáš Zlatohlávek, Věra Adámková, Aleš Hořínek, Tomáš Štulc, Tomáš Freiberger, Dana Dlouhá and Željko Reiner. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and International Journal of Molecular Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.